CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Neal J Thomas, MD, MSc
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
Principal Investigator - Robert F Tamburro, MD, MSc
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Sainte Justine
Montreal, Quebec, Canada
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Children'S Hospital of Los Angeles
Los Angeles, California, United States
- University of California San Francisco
San Francisco, California, United States
- Riley Children'S Hospital
Indianapolis, Indiana, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Weill Cornell Medical Center
New York, New York, United States
- Maria Fareri Children'S Hospital
Valhalla, New York, United States
- Rainbow Babies Hospital
Cleveland, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Texas Children'S Hospital
Houston, Texas, United States
- Children'S Hospital of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2010
- Primary completion
- 30 Sept 2015
- Completion
- 31 Oct 2015
- Last update posted
- 16 Mar 2018
- Registered enrollment
- 43
- Registry id
- NCT00999713
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.